• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid.

作者信息

Gillotte K L, Zaiou M, Lund-Katz S, Anantharamaiah G M, Holvoet P, Dhoest A, Palgunachari M N, Segrest J P, Weisgraber K H, Rothblat G H, Phillips M C

机构信息

Department of Biochemistry, MCP Hahnemann University, Philadelphia, Pennsylvania 19129, USA.

出版信息

J Biol Chem. 1999 Jan 22;274(4):2021-8. doi: 10.1074/jbc.274.4.2021.

DOI:10.1074/jbc.274.4.2021
PMID:9890960
Abstract

Lipid-free apolipoprotein (apo) A-I contributes to the reverse transport of cholesterol from the periphery to the liver by solubilizing plasma membrane phospholipid and cholesterol. The features of the apolipoprotein required for this process are not understood and are addressed in the current study. Membrane microsolubilization of human fibroblasts is not specific for apo A-I; unlipidated apos A-II, C, and E incubated with the fibroblast monolayers at a saturating concentration of 50 micrograms/ml are all able to release cholesterol and phospholipid similarly. To determine the properties of the apolipoprotein that drive the process, apo A-I peptides spanning the entire sequence of the protein were utilized; the peptides correspond to the 11- and 22-residue amphipathic alpha-helical segments, as well as adjacent combinations of the helices. Of the 20 helical peptides examined, only peptides representing the N-and C-terminal portions of the protein had the ability to solubilize phospholipid and cholesterol. Cholesterol efflux to the most effective peptides, 44-65 and 209-241, was approximately 50 and 70%, respectively, of that to intact apo A-I. Deletion mutants of apo E and apo A-I were constructed that have reduced lipid binding affinities as compared with the intact molecule. The proteins, apo A-I (Delta222-243), apo A-I (Delta190-243), apo E3 (Delta192-299) and apo E4 (Delta192-299) all exhibited a decreased ability to remove cellular cholesterol and phospholipid. These decreases correlated with the reduced ability of these proteins to penetrate into a phospholipid monomolecular film. Overall, the results indicate that insertion of amphipathic alpha-helices between the plasma membrane phospholipid molecules is a required step in the mechanism of apolipoprotein-mediated cellular lipid efflux. Therefore the lipid binding ability of the apolipoprotein is critical for efficient membrane microsolubilization.

摘要

相似文献

1
Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid.
J Biol Chem. 1999 Jan 22;274(4):2021-8. doi: 10.1074/jbc.274.4.2021.
2
Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.细胞内胆固醇和磷脂向无脂载脂蛋白及A类两亲性肽的外流。
Biochemistry. 1995 Jun 20;34(24):7955-65. doi: 10.1021/bi00024a021.
3
Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization.
J Lipid Res. 1998 Oct;39(10):1918-28.
4
The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.载脂蛋白结构对细胞游离胆固醇向高密度脂蛋白流出的影响。
J Biol Chem. 1994 Sep 16;269(37):22975-82.
5
Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.用于血浆载脂蛋白的一类新型两亲性螺旋肽的设计,这类肽可促进细胞胆固醇外流但不激活卵磷脂胆固醇酰基转移酶。
Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):580-8. doi: 10.1161/01.atv.17.3.580.
6
Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.脂质从成纤维细胞外流至载脂蛋白:依赖于细胞内未酯化胆固醇水平的升高。
J Lipid Res. 1992 Nov;33(11):1699-709.
7
Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids.载脂蛋白A-I结构对ABCA1介导的细胞脂质外流的影响。
J Biol Chem. 2004 Nov 26;279(48):49931-9. doi: 10.1074/jbc.M406924200. Epub 2004 Sep 21.
8
Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes.高密度脂蛋白介导胆固醇从细胞质膜流出的机制。
Atherosclerosis. 1998 Apr;137 Suppl:S13-7. doi: 10.1016/s0021-9150(97)00312-2.
9
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.模拟载脂蛋白A-I清除细胞胆固醇的合成两亲性螺旋肽。
J Clin Invest. 1994 Oct;94(4):1698-705. doi: 10.1172/JCI117515.
10
Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells.人成纤维细胞永生化导致载脂蛋白介导的细胞脂质清除减少及 cAMP 使其逆转:对丹吉尔病细胞无影响
J Lipid Res. 1999 Oct;40(10):1769-81.

引用本文的文献

1
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.自上而下蛋白质组学鉴定肝硬化进展的血浆蛋白质异构体特征
Mol Cell Proteomics. 2024 Dec;23(12):100876. doi: 10.1016/j.mcpro.2024.100876. Epub 2024 Nov 8.
2
Mapping the gut microecological multi-omics signatures to serum metabolome and their impact on cardiometabolic health in elderly adults.绘制肠道微生物宏基因组学特征图谱与血清代谢组学的关联及其对老年人心脏代谢健康的影响。
EBioMedicine. 2024 Jul;105:105209. doi: 10.1016/j.ebiom.2024.105209. Epub 2024 Jun 21.
3
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling.
缩小血脂异常患者管理中的差距:通过载脂蛋白分析迈向心血管精准诊断。
Clin Proteomics. 2024 Mar 1;21(1):19. doi: 10.1186/s12014-024-09465-w.
4
Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.无细胞、高密度脂蛋白特异性磷脂外排测定预测心血管疾病事件的发生。
J Clin Invest. 2023 Sep 15;133(18):e165370. doi: 10.1172/JCI165370.
5
Is reverse cholesterol transport regulated by active cholesterol?胆固醇逆向转运是否受活性胆固醇调节?
J Lipid Res. 2023 Jun;64(6):100385. doi: 10.1016/j.jlr.2023.100385. Epub 2023 May 9.
6
The role of C-terminal ionic residues in self-association of apolipoprotein A-I.载脂蛋白 A-I 自我聚集中 C 端离子残基的作用。
Biochim Biophys Acta Biomembr. 2023 Feb;1865(2):184098. doi: 10.1016/j.bbamem.2022.184098. Epub 2022 Dec 6.
7
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins.新型降脂药物降低心血管风险:超越他汀类药物。
Diabetes Metab J. 2022 Jul;46(4):517-532. doi: 10.4093/dmj.2022.0198. Epub 2022 Jul 27.
8
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies.了解髓过氧化物酶对血管壁中高密度脂蛋白(HDL)结构和功能的损伤:对基于HDL的治疗的启示。
Antioxidants (Basel). 2022 Mar 15;11(3):556. doi: 10.3390/antiox11030556.
9
Apolipoproteins in vascular biology and atherosclerotic disease.载脂蛋白在血管生物学和动脉粥样硬化疾病中的作用。
Nat Rev Cardiol. 2022 Mar;19(3):168-179. doi: 10.1038/s41569-021-00613-5. Epub 2021 Oct 8.
10
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis.健康与疾病中的脂质和脂蛋白:聚焦动脉粥样硬化靶向治疗
Biomedicines. 2021 Aug 9;9(8):985. doi: 10.3390/biomedicines9080985.